Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,13 USD | +1,43% | -2,74% | -69,22% |
Vakgebied
Aantal werknemers: 16
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ilya Rachman
CEO | Chief Executive Officer | 52 | 01-01-12 |
Gabriel Morris
DFI | Director of Finance/CFO | 38 | 01-03-21 |
Graham Ross
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-06-21 |
Nandan Oza
PRN | Corporate Officer/Principal | 61 | 01-05-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane Buchan
BRD | Director/Board Member | 60 | 01-07-21 |
Jason Hsu
BRD | Director/Board Member | 50 | 01-01-13 |
Magda Marquet
BRD | Director/Board Member | 65 | 01-06-21 |
Carey Ng
BRD | Director/Board Member | 45 | 01-11-19 |
Helen Adams
BRD | Director/Board Member | 65 | 01-06-21 |
Ilya Rachman
CEO | Chief Executive Officer | 52 | 01-01-12 |
Gabriel Morris
DFI | Director of Finance/CFO | 38 | 01-03-21 |
Director/Board Member | 39 | 22-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 26 468 783 | 14 277 691 ( 53,94 %) | 72 363 ( 0,2734 %) | 53,94 % |
Bedrijfsgegevens
Immix Biopharma, Inc.
11400 West Olympic Boulevard Suite 200
90064, Los Angeles
+
http://www.immixbio.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-69,22% | 56,22 mln. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,36 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |
- Beurs
- Aandelen
- Koers IMMX
- Onderneming Immix Biopharma, Inc.